Left behind: The potential problem of residual cancer

由 Shayegan, Bobby
出版 2013

Mitigating pelvic recurrence and improving overall survival

由 Shayegan, Bobby
發表在 Can Urol Assoc J (2016)

Prostate cancer, ESMO 2016

由 Shayegan, Bobby
發表在 Can Urol Assoc J (2016)

Management of the urethra in urothelial bladder cancer

由 Kanaroglou, Androniki, Shayegan, Bobby
出版 2009

Complete resection of a primitive neuroectodermal tumour arising in the bladder of a 31-year-old female after neoadjuvant chemotherapy

由 Lam, Cameron J., Shayegan, Bobby
發表在 Can Urol Assoc J (2016)

Patient centered care for prostate cancer—how can artificial intelligence and machine learning help make the right decision for the right patient?

由 Wong, Nathan C., Shayegan, Bobby
發表在 Ann Transl Med (2019)

Images in urology: Localized primary amyloidosis of the urinary bladder

由 Varghese, Shawn, Wong, Nathan Colin, Shayegan, Bobby
發表在 Can Urol Assoc J (2018)

Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report

由 Chandhoke, Gursimran, Shayegan, Bobby, Hotte, Sebastien J.
發表在 J Med Case Rep (2018)

Defining a new testosterone threshold for medical castration: Results from a prospective cohort series

由 Dason, Shawn, Allard, Christopher B., Tong, Justin, Shayegan, Bobby
出版 2013

Pure laparoscopic unilateral nephrectomy for a patient with a polycystic horseshoe kidney

由 Dason, Shawn, Allard, Christopher B., Shayegan, Bobby, Piercey, Kevin
發表在 Can Urol Assoc J (2014)

Contemporary agents in the management of metastatic castration-resistant prostate cancer

由 Kapoor, Anil, Wu, Christopher, Shayegan, Bobby, Rybak, Adrian P.
發表在 Can Urol Assoc J (2016)

Towards development and validation of an intraoperative assessment tool for robot-assisted radical prostatectomy training: results of a Delphi study

由 Morris, Christopher, Hoogenes, Jen, Shayegan, Bobby, Matsumoto, Edward D.
發表在 Int Braz J Urol (2017)

Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians

由 Shayegan, Bobby, Pouliot, Frédéric, So, Alan, Fernandes, John, Macri, Joseph
發表在 Can Urol Assoc J (2017)

Utility of preoperative 3 Tesla pelvic phased-array multiparametric magnetic resonance imaging in prediction of extracapsular extension and seminal vesicle invasion of prostate can...

由 Lee, Taehyoung, Hoogenes, Jen, Wright, Ian, Matsumoto, Edward D., Shayegan, Bobby
發表在 Can Urol Assoc J (2017)

Canadian Urological Association guideline: Perioperative thromboprophylaxis and management of anticoagulation

由 Violette, Philippe D., Lavallée, Luke T., Kassouf, Wassim, Gross, Peter L., Shayegan, Bobby
發表在 Can Urol Assoc J (2019)

Case: Spontaneous regression of post-radical prostatectomy prostate-specific antigen elevation without adjuvant therapy in a patient with lymph node metastasis

由 Lee, Taehyoung, Guo, Yanbo, Vij, Saahil, Bansal, Rahul, Wong, Nathan C., Shayegan, Bobby
發表在 Can Urol Assoc J (2017)

Compliance of the recurrent renal stone former with current best practice guidelines

由 Bos, Derek, Kim, Kevin, Hoogenes, Jen, Lambe, Shahid, Shayegan, Bobby, Matsumoto, Edward D.
發表在 Can Urol Assoc J (2018)

Urothelial carcinoma involving the distal penis

由 Dason, Shawn, Sheikh, Adeel, Wang, Jing Gennie, Tauqir, Syeda, Davies, Timothy O., Shayegan, Bobby
出版 2012

High-Intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response

由 Dason, Shawn, Wong, Nathan C., Allard, Christopher B., Hoogenes, Jen, Orovan, William, Shayegan, Bobby
發表在 Int Braz J Urol (2018)

A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy

由 Pawson, Amy, Ghumman, Zonia, Kuo, Phillip H., Jadvar, Hossein, Bartel, Twyla, Shayegan, Bobby, Zukotynski, Katherine
發表在 Can Urol Assoc J (2020)